|
End-of-day quote
Johannesburg S.E.
2026-08-18
|
5-day change | 1st Jan Change | ||
| 140.55 ZAR | -0.98% |
|
-4.27% | +20.34% |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic injection | RE |
| Market Cap | 62.41B 3.84B 3.31B 3.12B 2.83B 5.33B 368B 5.41B 36.58B 14.34B 184B 14.41B 14.1B 613B | P/E 2026 * |
14.3x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 75.28B 4.63B 4B 3.76B 3.42B 6.43B 444B 6.53B 44.13B 17.3B 222B 17.38B 17B 739B | EV / Sales 2026 * |
2x | EV / Sales 2027 * | 1.56x |
| Free-Float |
59.64% | Yield 2026 * |
1.89% | Yield 2027 * | 1.79% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | -0.98% | ||
| 1 week | -4.27% | ||
| Current month | -5.73% | ||
| 1 month | -6.50% | ||
| 3 months | +0.81% | ||
| 6 months | +12.44% | ||
| Current year | +20.34% |
| 1 week | 138.69 |  | 147.06 |
| 1 month | 138.69 | | 158.55 |
| Current year | 104.38 | | 160.79 |
| 1 year | 90.7 | | 160.79 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 367.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | -4.27% | +22.99% | -25.53% | 3.84B | |
| +1.03% | -2.57% | +16.45% | +66.53% | 46.96B | |
| +0.12% | -1.59% | +47.86% | +123.16% | 39.63B | |
| -0.92% | -3.08% | -8.46% | +14.92% | 12.07B | |
| -0.67% | -8.17% | +11.84% | +69.44% | 11.61B | |
| +0.58% | 0.00% | +30.65% | +147.62% | 9.11B | |
| +0.54% | -0.23% | +21.04% | +40.85% | 7.47B | |
| +0.80% | +1.82% | +43.27% | -11.49% | 7.18B | |
| -3.28% | -2.63% | +14.59% | +187.68% | 6.79B | |
| -0.97% | -2.30% | -30.37% | +24.93% | 5.75B | |
| Average | -0.39% | -1.95% | +16.99% | +63.81% | 15.04B | |
| Weighted average by Cap. | +0.10% | -2.91% | +23.03% | +78.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.31B 2B 1.88B 1.71B 3.21B 222B 3.26B 22.05B 8.64B 111B 8.69B 8.5B 369B | 38.86B 2.39B 2.06B 1.94B 1.76B 3.32B 229B 3.37B 22.78B 8.93B 115B 8.97B 8.78B 381B |
| Net income | 4.8B 295M 255M 240M 218M 410M 28.27B 416M 2.81B 1.1B 14.14B 1.11B 1.08B 47.1B | 5B 307M 265M 250M 227M 427M 29.43B 433M 2.93B 1.15B 14.72B 1.15B 1.13B 49.03B |
| Net Debt | 12.88B 792M 684M 644M 585M 1.1B 75.88B 1.12B 7.55B 2.96B 37.95B 2.97B 2.91B 126B | -1.74B -107M -92.16M -86.71M -78.81M -148M -10.22B -150M -1.02B -399M -5.11B -401M -392M -17.03B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | ZAR 140.55 | -0.98% | 3,249,353 |
| 26-08-17 | ZAR 141.94 | -1.21% | 969,449 |
| 26-08-14 | ZAR 143.68 | +0.24% | 1,674,274 |
| 26-08-13 | ZAR 143.33 | -1.39% | 2,304,506 |
| 26-08-12 | ZAR 145.35 | -1.00% | 2,344,824 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
